Hoge Stephen's Form 4 filing
Moderna, Inc. (MRNA) · filed Mar 25, 2022
- Accession no.
- 0001127602-22-010388
- Filed
- Mar 25, 2022
- Trade date
- Mar 23-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.60M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoge StephenCIK 0001760669 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,627,532 | Direct | |
| Mar 23, 2022 | Common Stock | MOption exerciseAcquired | +10,000 | $0.99 | +$9,900 | 1,637,532 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −700 | $177.62F2 | −$124,334 | 1,636,832 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −3,169 | $178.75F3 | −$566,458.75 | 1,633,663 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −1,674 | $179.72F4 | −$300,851.28 | 1,631,989 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −1,657 | $180.94F5 | −$299,817.58 | 1,630,332 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −900 | $181.97F6 | −$163,773 | 1,629,432 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −1,100 | $183.04F7 | −$201,344 | 1,628,332 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −600 | $183.78F8 | −$110,268 | 1,627,732 | Direct | |
| Mar 23, 2022 | Common Stock | SSaleDisposed | −5,200 | $184.66F9 | −$960,232 | 1,622,532 | Direct | |
| Mar 24, 2022 | Common Stock | MOption exerciseAcquired | +5,000 | $10.90 | +$54,500 | 1,627,532 | Direct | |
| Mar 24, 2022 | Common Stock | SSaleDisposed | −5,000 | $175.52 | −$877,600 | 1,622,532 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 111,972 | Direct | |
| Mar 23, 2022 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 77,431 | Direct | |
| Mar 24, 2022 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 106,972 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $177.20 to $178.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $178.27 to $179.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $179.29 to $180.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $180.48 to $181.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $181.51 to $182.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $182.53 to $183.53. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $183.59 to $184.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.62 to $184.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.